Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible low-dose GnRH antagonist and prednisone in IVF antagonist cycles
ChiCTR1900021024Phase 3Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cetrorelix and prednisone in infertility (3 arms), sponsored by Ruijin Hospital. Primary endpoint: Clinical pregnancy rate. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
cetrorelixprednisone
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR1900021024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021024.